Anti-ADAMTS-19 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting the metalloproteinase domain of human ADAMTS-19, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey
UniProt
Q8TE59
Size
100ug
Cat. #
RP2ADAMTS19

In stock

SKU
RP-ADAMTS19

Options

As low as: $130.00

Target Overview

ADAMTS-19 (a disintegrin and metalloproteinase with thrombospondin motifs 19, UniProt Q8TE59) is a secreted metalloproteinase belonging to the ADAMTS family of extracellular matrix-remodeling enzymes. The protein comprises 1,213 amino acids and is classified under EC 3.4.24, indicating peptidase activity. ADAMTS-19 is localized to the extracellular space and extracellular matrix, where it is predicted to participate in the proteolytic processing of matrix substrates, though specific physiological substrates remain incompletely characterized. The ADAMTS family is defined by a conserved modular architecture that includes a metalloproteinase domain, a disintegrin-like domain, and one or more thrombospondin type-1 repeats. Members of this family regulate diverse processes including procollagen processing, versican cleavage, and angiogenesis inhibition. ADAMTS-19 has attracted research interest in the context of connective tissue biology and potential roles in developmental and disease processes, including recent genetic association studies in neurodegenerative and reproductive contexts.

Background

The ADAMTS proteinase family consists of 19 secreted zinc metalloproteinases that share structural homology but exhibit distinct substrate specificities and tissue expression patterns. ADAMTS-19 remains among the less extensively characterized family members compared to prototypical enzymes such as ADAMTS-1, -4, and -5. Recent work has implicated ADAMTS and ADAMTSL gene variants in heritable connective tissue disorders, underscoring the clinical relevance of this protein family in maintaining extracellular matrix integrity (Alcocer AD et al, 2026). Genetic studies have begun to link ADAMTS-19 variants to complex disease phenotypes. Eubanks and colleagues identified an increased burden of rare variants across gene expression networks, including ADAMTS-19, in sporadic Parkinson's disease cohorts, suggesting potential modifying roles in neurodegeneration (Eubanks E et al, 2025). Additional genome-wide association analyses have nominated ADAMTS-19 as a candidate gene in endometriosis-associated ovarian cancer and polycystic ovarian syndrome models, though mechanistic studies remain limited. The extracellular matrix is now recognized as a dynamic regulator of cell signaling, migration, and differentiation. Proteolytic remodeling by ADAMTS proteinases influences morphogenesis, tissue repair, and pathological fibrosis. Understanding the substrate repertoire and regulatory mechanisms governing ADAMTS-19 activity will be essential to elucidate its contributions to these processes. Triple Point Biologics offers two rabbit polyclonal antibodies raised against the metalloproteinase domain of ADAMTS-19, validated for Western blot, with predicted cross-reactivity in primate species.

References

  1. Alcocer AD et al (2026) ADAMTS and ADAMTSL mutations in connective tissue disorders. Physiology (Bethesda). PubMed · 10.1152/physiol.00043.2025
  2. Eubanks E et al (2025) Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease. Cell Rep. PubMed · 10.1016/j.celrep.2025.115636
  3. Yang H et al (2024) Identification and Validation of Prognostic Markers for Endometriosis-Associated Ovarian Cancer. Int J Med Sci. PubMed · 10.7150/ijms.97024

Additional Specifications

Size 100 µg
Gene Symbol ADAMTS19
UniProt ID Q8TE59
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey
Pack Size 100ug
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 331-551.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 28-322.
Alternate Names A disintegrin and metalloproteinase with thrombospondin motifs 19, ADAM-TS 19, ADAM-TS19, ADAMTS-19, EC 3.4.24.-

Frequently Asked Questions

What molecular weight should I expect for ADAMTS-19 on Western blot?

Full-length ADAMTS-19 has a predicted molecular weight of approximately 134 kDa based on its 1,213 amino acid sequence. However, as a secreted metalloproteinase that undergoes post-translational modification including glycosylation, you may observe the band migrating between 140-150 kDa under reducing conditions. ADAMTS family members are also subject to proteolytic processing, so lower molecular weight bands may represent catalytically processed forms or degradation products. When optimizing detection, consider running a broader gel window (75-200 kDa) initially to capture both full-length and processed species in your sample type.

What is the recommended starting dilution for ADAMTS-19 antibody in Western blot?

We recommend a starting dilution of 1:1000 for Western blot applications based on validation testing. This polyclonal antibody typically provides clean signal at this dilution when detecting ADAMTS-19 from cell lysates or conditioned media enriched for secreted proteins. Because ADAMTS-19 is an extracellular matrix protein with variable expression across cell types, you may need to adjust between 1:500 and 1:2000 depending on endogenous expression levels and sample concentration. For samples with low ADAMTS-19 abundance, concentrating conditioned media by ultrafiltration or TCA precipitation prior to loading can improve detection without compromising antibody dilution.

Is this ADAMTS-19 antibody suitable for detecting monkey or mouse samples?

The antibody is validated for human ADAMTS-19 detection and predicted to cross-react with non-human primate samples, including monkey species, based on high sequence homology in the immunogen region. Mouse reactivity has not been validated. Human and cynomolgus monkey ADAMTS-19 share greater than 95% sequence identity, making cross-reactivity highly probable, though we recommend confirming signal specificity with appropriate controls when working with non-human primate samples. If you require validated mouse reactivity, contact us to discuss epitope alignment, as rodent ADAMTS-19 orthologs show divergence in certain domains that may affect recognition.

What sample types work best for detecting ADAMTS-19?

Because ADAMTS-19 is a secreted extracellular matrix metalloproteinase, conditioned media from cultured cells often yields stronger signal than whole-cell lysates. If working with tissue samples, extraction buffers containing mild detergents that preserve ECM-associated proteins are preferable to harsh lysis conditions. For Western blot, we recommend including protease inhibitors that spare metalloproteinase activity during lysis to avoid artifactual degradation. Serum or plasma can also be probed, though ADAMTS-19 abundance in circulation is typically low under basal conditions. Enrichment strategies such as heparin affinity capture may improve detection from complex biological fluids given the thrombospondin domains present in ADAMTS-19.

Are there known isoforms or splice variants of ADAMTS-19 I should be aware of?

ADAMTS-19 gene structure permits alternative splicing, though functional characterization of variants remains limited in the published literature. The canonical 1,213 amino acid isoform is the predominant form annotated in UniProt (Q8TE59-1). Shorter transcripts have been detected in transcript databases but their translation and biological relevance are not well established. On Western blot, multiple bands may arise from proteolytic maturation rather than splice variation, as ADAMTS enzymes undergo activation cleavage of their propeptide domains. If you observe multiple immunoreactive species, consider whether they represent precursor, mature, or processed forms rather than assuming distinct isoforms without further validation.

What controls should I include when using this ADAMTS-19 antibody?

Include a negative control using lysate or conditioned media from cells with low or absent ADAMTS-19 expression to assess non-specific binding. A positive control consisting of recombinant ADAMTS-19 protein or lysate from cells engineered to overexpress ADAMTS-19 helps confirm antibody specificity and sets a benchmark for band migration. For blocking peptide controls, contact us regarding epitope sequence information. When working with IHC or immunofluorescence applications, secondary-antibody-only controls are essential. Because ADAMTS-19 is context-dependently expressed, consider stimulating cells with TGF-β or other ECM-remodeling cues if basal expression is undetectable in your system.

How should I store the ADAMTS-19 antibody and what is the expected stability?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can compromise polyclonal antibody performance over time. Once thawed, an aliquot can be kept at 4°C for up to one month for routine use. Addition of glycerol (to 50%) or carrier protein stabilizers is compatible with storage if you prefer a non-frozen stock, though we supply the antibody in a formulation optimized for frozen storage. Do not store diluted antibody; prepare working dilutions fresh in blocking buffer on the day of use. Under proper storage at -20°C, rabbit polyclonal antibodies typically retain activity for at least two years from the date of manufacture.

Can this antibody detect ADAMTS-19 in formalin-fixed paraffin-embedded tissue?

This antibody is validated for Western blot; immunohistochemistry/immunofluorescence validation is in progress, which includes FFPE tissue sections, in addition to Western blot. Antigen retrieval is generally required for optimal ADAMTS-19 detection in FFPE samples. We recommend heat-mediated retrieval in citrate buffer (pH 6.0) as a starting condition, though Tris-EDTA (pH 9.0) may also be tested if signal is weak. Because ADAMTS-19 is an extracellular matrix protein, staining is expected in the interstitial space and pericellular regions rather than intracellularly. Validate staining patterns with tissue known to express ADAMTS-19, such as cartilage or connective tissue undergoing remodeling, and include isotype controls to confirm specificity.

Validation imagery coming soon

Western blot validation figures for RP-ADAMTS19 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • A disintegrin and metalloproteinase with thrombospondin motifs 19
  • ADAM-TS 19
  • ADAM-TS19
  • ADAMTS-19
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →